跳至主要内容
临床试验/TCTR20230206007
TCTR20230206007Unknown不适用

Risk factors of osteonecrosis of the jaw in patients with multiple myeloma receiving intravenous bisphosphonates: Retrospective study

Chulalongkorn University0 个研究点目标入组 120 人开始时间: 2023年2月6日最近更新:
适应症

试验速览

阶段
不适用
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
N/A (No limit) 至 N/A (No limit)(—)
性别
All

入选标准

  • 1.Patients diagnosed with multiple myeloma received intravenous bisphosphonates.
  • 2.Patients who evaluate and/or treated as a new case or relapse of multiple myeloma.

排除标准

  • 1.Patients had a history of radiation therapy to the jaws or of tumors or cysts.
  • 2.Undergoing a radiation therapy in the head and neck region
  • 3.Patients had a history of osteonecrosis of the jaw before treating multiple myeloma with IV bisphosphonate.

研究者

相似试验